Targeted Therapy for Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference101 articles.
1. Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies;Roop;Future Oncol,2012
2. Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer;Schwartzberg;Oncologist,2010
3. Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer;Baselga;N Engl J Med,2012
4. Signaling regulation of genomic and nongenomic functions of estrogen receptors;Acconcia;Cancer Lett,2006
5. An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer;Crump;Breast Cancer Res Treat,1997
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A novel computer-assisted tool for 3D imaging of programmed death-ligand 1 expression in immunofluorescence-stained and optically cleared breast cancer specimens;BMC Cancer;2024-01-24
2. Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions;Recent Patents on Anti-Cancer Drug Discovery;2024-01-19
3. The application of radionuclide therapy for breast cancer;Frontiers in Nuclear Medicine;2024-01-10
4. Enhancing Breast Cancer Drug Development: Predicting Bioac-tivity and ADMET Properties of ERα Targeting Compounds through Machine Learning;2023 5th International Conference on Machine Learning, Big Data and Business Intelligence (MLBDBI);2023-12-15
5. Surfaceome Profiling Suggests Potential of Anti-MUC1×EGFR Bispecific Antibody for Breast Cancer Targeted Therapy;Journal of Immunotherapy;2023-07-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3